| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/19/2010 | US7649009 N-(trans-4-tert-butylcyclohexyl)-1-{4-[(1h-tetrazol-5-ylamino)carbonyl]benzyl }-3-(3,4,5-trifluoropbenyl)-1h-pyrazole-5-carboxamide; type 2 diabetes, hyperglycemia, diabetes or insulin resistance, Syndrome X, atherosclerosis |
| 01/19/2010 | US7649004 Pyridine derivatives |
| 01/19/2010 | US7649003 Substituted triazole derivatives as oxytocin antagonists |
| 01/19/2010 | US7649002 (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists |
| 01/19/2010 | US7648992 Metalloproteinase 9 and/or 12 inhibitors; such as 5-({[4-[(2-cyclopropylpyrimidin-5-yl)ethynyl]-3,6-dihydropyridin-1(2H1)-yl]sulfonyl}methyl)-5-methylimidazolidine-2,4-dione; synthesis; asthma, chronic obstructive pulmonary disease |
| 01/19/2010 | US7648990 Chemical compounds |
| 01/19/2010 | US7648989 Indolylmaleimide derivatives as PKC inhibitors |
| 01/19/2010 | US7648986 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine |
| 01/19/2010 | US7648979 5-amido-(1H-indol-2-yl)-piperazin-1-yl-methanone derivatives |
| 01/19/2010 | US7648971 Thrombopoietin mimetics |
| 01/19/2010 | US7648959 Methods and compositions for the treatment of diseases of the eye |
| 01/19/2010 | US7648738 for photopolymerization; photography, relief imaging; color filters |
| 01/19/2010 | CA2402751C Decahydro-isoquinolines |
| 01/19/2010 | CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors |
| 01/19/2010 | CA2239904C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/14/2010 | WO2010006191A1 4-phenoxymethylpiperidines as modulators of gpr119 activity |
| 01/14/2010 | WO2010005879A1 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/14/2010 | WO2010005783A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors |
| 01/14/2010 | WO2010005782A1 Sulfone compounds which modulate the cb2 receptor |
| 01/14/2010 | WO2010005692A2 Insecticidal cyclic carbonyl amidines |
| 01/14/2010 | WO2010005572A2 Alpha-keto heterocycles as faah inhibitors |
| 01/14/2010 | WO2010005385A1 2-amino-6-alkyl substituted pyridine derivatives useful as p2y12 inhibitors 308 |
| 01/14/2010 | WO2010005384A1 Ketone pyridine analogues and their use in the treatment of cardiovascular disorders |
| 01/14/2010 | WO2010005087A1 Amidine derivative |
| 01/14/2010 | WO2010004782A1 Prolineamide derivative, salt thereof with acid, organic catalyst consisting of the same and method of producing β-hydroxycarbonyl compound using the organic catalyst |
| 01/14/2010 | WO2010004761A1 Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
| 01/14/2010 | WO2010004580A2 Process for preparing indole derivatives |
| 01/14/2010 | WO2010004571A2 Process for purification of rabeprazole sodium |
| 01/14/2010 | WO2010004517A1 Triazole derivatives useful for the treatment of diseases |
| 01/14/2010 | WO2010004390A1 Quinazoline dione derivatives as trpa1 modulators |
| 01/14/2010 | WO2010004347A1 Heterocyclic gpcr agonists |
| 01/14/2010 | WO2010004343A1 Piperidinyl gpcr agonists |
| 01/14/2010 | WO2010004198A2 Antineoplastic derivatives, preparation thereof, and therapeutic use thereof |
| 01/14/2010 | WO2010003974A2 Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
| 01/14/2010 | WO2010003760A2 Fluoro-substituted 3,4-diaryl-4,5-dihydro-1h-pyrazole-1-carboxamidine derivatives having cb1-antagonistic activity |
| 01/14/2010 | WO2010003350A1 1-substituted pyridyl-pyrazolyl amide compounds and uses thereof |
| 01/14/2010 | WO2009132453A8 Cyclylamine derivatives as calcium channel blockers |
| 01/14/2010 | WO2009126530A3 Piperidine derivatives as cgrp receptor antagonists |
| 01/14/2010 | WO2009121872A3 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 01/14/2010 | US20100010230 Method for the purification of lansoprazole |
| 01/14/2010 | US20100010222 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient |
| 01/14/2010 | US20100010219 Method for producing pyrrolidine compound |
| 01/14/2010 | US20100010049 Novel Tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof |
| 01/14/2010 | US20100010048 Fungicide 2-pyridyl-methylene-carboxamide derivatives |
| 01/14/2010 | US20100010047 Isotopically substituted proton pump inhibitors |
| 01/14/2010 | US20100010045 PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 01/14/2010 | US20100010042 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 01/14/2010 | US20100010040 Triazol Derivatives Useful For The Treatment of Diseases |
| 01/14/2010 | US20100010025 Pyrimidine Derivatives |
| 01/14/2010 | US20100010024 Use of1,4-diaryl-dihydropyrimidine-2-on derivatives for treating pulmonary arterial hypertension |
| 01/14/2010 | US20100010008 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/14/2010 | US20100010007 Piperidine derivatives as modulators of chemokine receptor ccr5 |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100010003 Pyrimidine Derivatives And Their Use As Pesticides |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009987 Aminothiazole derivatives as inhibitors of mark |
| 01/14/2010 | US20100009986 Substituted heteroaryl derivatives |
| 01/14/2010 | US20100009980 Novel 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
| 01/14/2010 | US20100009979 Pharmaceuticals containing fluoroquinolones |
| 01/14/2010 | US20100009972 Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Compound |
| 01/14/2010 | US20100009971 Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Compound |
| 01/14/2010 | US20100009967 Solid dosage formulations of telcagepant potassium |
| 01/14/2010 | US20100009966 Substituted lactams as inhibitors of abeta protein production |
| 01/14/2010 | US20100009965 Cyclic malonamides as inhibitors of abeta protein production |
| 01/14/2010 | US20100009964 Compounds Which Modulate The CB2 Receptor |
| 01/14/2010 | US20100009962 Benzyl-substituted quinolone m1 receptor positive allosteric modulators |
| 01/14/2010 | US20100009956 Novel substituted pyrimidines as cysteine protease inhibitors |
| 01/14/2010 | US20100009896 Capture agents and related compositions, methods and systems |
| 01/14/2010 | CA2730511A1 4-phenoxymethylpiperidines as modulators of gpr119 activity |
| 01/14/2010 | CA2730280A1 5-quinolinone and imidazopyridine compounds and use thereof |
| 01/14/2010 | CA2730251A1 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/14/2010 | CA2730116A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors |
| 01/14/2010 | CA2730071A1 Antineoplastic derivatives of 4-oxo-l, 4-dihydro-quinolin?, preparation thereof, and therapeutic use thereof |
| 01/14/2010 | CA2730037A1 Sulfone compounds which modulate the cb2 receptor |
| 01/14/2010 | CA2729988A1 Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
| 01/14/2010 | CA2729845A1 Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
| 01/14/2010 | CA2728042A1 Piperidinyl gpcr agonists |
| 01/14/2010 | CA2727146A1 Fluoro-substituted 3,4-diaryl-4,5-dihydro-1h-pyrazole-1-carboxamidine derivatives having cb1-antagonistic activity |
| 01/14/2010 | CA2726686A1 Triazole derivatives useful for the treatment of diseases |
| 01/13/2010 | EP2143727A1 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 01/13/2010 | EP2143722A1 Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
| 01/13/2010 | EP2143721A1 Hydrazide compound and harmful arthropod-controlling agent containing the same |
| 01/13/2010 | EP2143714A1 Tetrahydroisoquinoline compound |
| 01/13/2010 | EP2143713A1 Novel pyrrolinone derivative and medicinal composition containing the same |
| 01/13/2010 | EP2143444A1 Compositions for inhibition of anglogenesis |
| 01/13/2010 | EP2142536A1 Aminopyrimidine derivatives as glutaminyl cyclase inhibitors |
| 01/13/2010 | EP2142532A1 Novel imatinib camsylate and method for preparing thereof |
| 01/13/2010 | EP2142531A1 Benzimidazole cannabinoid agonists |
| 01/13/2010 | EP2142530A2 Process for producing pesticidal benzamide compounds |
| 01/13/2010 | EP2142529A2 Trpv1 antagonists and uses thereof |
| 01/13/2010 | EP2142528A1 1-(1-benzylpiperidin-4-yl)benzimidaz0le -5-carboxylic acid derivatives for the treatment of diabetes mellitus |
| 01/13/2010 | EP2142527A1 Pyridine and pyrimidine derivatives as mglur2 antagonists |
| 01/13/2010 | EP2142521A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 01/13/2010 | EP2142514A1 Thiourea derivatives as glutaminyl cyclase inhibitors |
| 01/13/2010 | EP2142512A2 Imidazolidine carboxamide derivatives as p2x7 modulators |
| 01/13/2010 | EP2141994A1 Multi-ring compounds and uses thereof |
| 01/13/2010 | EP2027108B1 Histamine receptor antagonists comprising an azepin core |
| 01/13/2010 | EP2021337B1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 01/13/2010 | EP1910298B1 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants |
| 01/13/2010 | EP1465886B1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |